AVTR News and Press, Avantor Inc. From 04/29/21

Image source: The Motley Fool. AVANTOR (NYSE: AVTR) Q1 2021 Earnings Call Apr 28, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: AVANTOR (AVTR) Q1 2021 Earnings Call Transcript

Avantor (AVTR): Q1 Non-GAAP EPS of $0.35 beats by $0.07; GAAP EPS of $0.25 beats by $0.07.Revenue of $1.79B (+17.8% Y/Y) beats by $90M.Press Release For further details see: Avantor EPS beats by $0.07, beats on revenue

Avantor® Reports First Quarter 2021 Results - Revenue of $1.79 billion, increase of 17.5%; organic revenue growth of 13.5% - Net income of $164.0 million; Adjusted EBITDA of $363.1 million - Diluted GAAP EPS of $0.25; adjusted EPS of $0.35 - Operating cash flow ...

Avantor, Inc. continues to present a compelling investment case, with industry drivers and portfolio insulators tied into the debate. The company hedges the top line against the downside and customer risk as each customer/account is exposed to only 3-4% of total sales. Deep custom...

Avantor® to Present at BofA Securities 2021 Virtual Health Care Conference PR Newswire RADNOR, Pa. , April 27, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life ...

Avantor ([[AVTR]] +0.5%) announced plans to expand its global capacity in single-use technologies used for the production of biologics and vaccines.In a statement, the company highlighted its efforts to increase the single-use manufacturing footprint by 30% and double the cleanroom space...

Avantor® to Boost Global Production of Single­-Use Technologies and Address Growing Biopharma Demand Increases single-use manufacturing footprint and cleanroom space in the U.S. and Europe Enables reliable supply of critical materials used in the manufacture of bio...

/C O R R E C T I O N -- Avantor and Financial News/ PR Newswire In the news release, Avantor® Declares Dividend on Mandatory Convertible Preferred Stock, issued 21-Apr-2021 by Avantor and Financial News over PR Newswire, we are advised by the company that the da...

Solid biopharma demand, rising diagnostic trends, and the economic recovery will support a ‘healthy’ Q1 revenue growth argues UBS analyst Dan Brennan and the team in a Q1 2021 preview written on the sector of life sciences & diagnostic tools.The firm picks IQVIA Holdings ([[...

Avantor Inc. (NYSE:AVTR) traded at a new 52-week high today of $33.30. This new high was reached on approximately average trading volume as 3.1 million shares traded hands, while the average 30-day volume is approximately 4 million shares. Avantor Inc is involved in providing products an...